Outcome of Board Meeting

REF: CHEMFAB/SEC/2026-27 29th July, 2026 BSE Limited National Stock Exchange of India Limited Corporate Relationship Department The Manager, Listing Department Phiroze Jeejeebhoy Towers, “Exchange Plaza” Dalal Street, Bandra - Kurla Complex, Bandra (E) Mumbai- 400 001. Mumbai - 400 051 BSE – Scrip Code: 541269 NSE Symbol: CHEMFAB Dear Sir/Madam, Sub: Outcome of the Board Meeting and Intimation under Regulation 30 In continuation to Company’s intimation of Board meeting filed with BSE and NSE on 23rd July, 2026, we wish to inform you that in the Board meeting held today i.e., 29th July, 2026, the Board inter-alia considered and approved the following: 1. Un-Audited Standalone and Consolidated Financial Results along with the Limited Review Report issued by the Statutory Auditors of the company for the quarter ended 30th June, 2026 as recommended by the Audit committee at its meeting held earlier in the day. 2. Appointment of M/s. M S K A & Associates LLP (FRN. 001595S/S000168) as the Statutory Auditors of the Company for the first term of five consecutive years subject to the approval of the Shareholders of the Company at the forthcoming Annual General Meeting (AGM). The details required as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule Ill thereof and SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dt.30.01.2026, as amended from time to time is enclosed as Annexure I. The said Meeting commenced at 12:00 P.M. and concluded at 6:00 P.M. Thanking You, Yours faithfully, For CHEMFAB ALKALIS LIMITED Bharatraj Panchal Company Secretary FCS: 9828 Annexure-1 Details of the Auditors S.No Description of the Statutory Auditor Details 1. Name of the Statutory Auditor and Firm M S K A & Associates LLP, Chartered Registration Number (FRN) Accountants (FRN. 001595S/S000168) 2. Reason for Change Appointment as the Statutory Auditor of the Company, subject to the approval of the shareholders at the ensuing Annual General Meeting ("AGM"), consequent upon the expiry of the tenure of the existing Statutory Auditor, Deloitte Haskins & Sells LLP. 3. Date of appointment From the conclusion of the ensuing Annual General Meeting, subject to the approval of shareholders. 4. Term of appointment For the first term of five consecutive years, commencing from the conclusion of ensuing Annual General Meeting till the conclusion of 22nd Annual General Meeting of the Company, subject to the approval of shareholders at the ensuing AGM. 5. Brief Profile MSKA & Associates LLP is an Indian LLP registered with the Institute of Chartered Accountants of India (ICAI) and the PCAOB (US Public Company Accountancy Oversight Board) which offers a wide range of services in Audit Assurance, Tax and Advisory domain led by industry experts with deep knowledge pockets and driven by a commitment to deliver quality services to all clients. Chartered Accountants ASV N Ramana Tower, 52, Venkatnarayana Road T. Nagar Deloitte Chennai 600 017 Tamil Nadu, India Haskins & Sells LLP Tel: +91 44 6688 5000 Fax: +91 44 6688 5050 INDEPENDENT AUDITOR'S REVIEW REPORT ONREVIEW OF INTERIM STANDALONE FINANCIAL RESULTS TO THE BOARD OF DIRECTORS OF CHEMFAB ALKALIS LIMITED 1. We have reviewed the accompanying Statement of Standalone Unaudited Financial Results of CHEMFAB ALKALIS LIMITED ("the Company") for the quarter ended 30 June 2026 ("the Statement"), being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("the LODR Regulations") . 2. This Statement, which is the responsibility of the Company's Management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the LODRRegulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity', issued by the Institute of Chartered Accountants of India (ICAI). A review of interim financial information consists of making inquiries, primarily of the Company's personnel responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under Section 143(10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. For Deloitte Haskins & Sells LLP Chartered Accountants (Firm's Registration No. 117366W/W -100018) Digitally signed p Us h a byPUsha Parvathy Parvathy pate 2626.07.29 16.25:26 +05'30' P Usha Parvathy Partner Membership No. 207704 UDIN:26207704ZOZTBT2069 Place: Chennai Date: 29July2026 Regd. Office: One International Center, Tower 3, 31st floor, Senapati Bapat Marg. Elphinstone Road (West), Mumbai-400 013, Maharashtra, India. Deloitte Haskins & Sells LLP is registered with Limited Liability having LIP identification No; AAB-8737 Chemfab Alkalis Limited CIN:L24290TN2009PLC071563 Regd. Office: Team House, GST Salai, Vandalur, Chennai 600 048. Phone No: +91 44 66799595 (Amount Rs. In Lakhs) STATEMENT OF STANDALONE FINANCIAL RESULTS FOR THE QUARTER ENDED 30/06/2026 Preceding Corresponding 3 Months Previous year 3 Months 3 months ended ended ended ended 30/06/2025 in the SI. No. Particulars 30/06/2026 31/03/2026 31/03/2026 previous year (Unaudited) (Refer Note 6) (Unaudited) (Audited) 1 Income (a) Revenue from Operations 7,302.14 6,872.61 8,758.10 28,856.60 (b) Other Income 181.28 401.03 105.66 827.45 Total Income 7,483.42 7,273.64 8,863.76 29,684.05 2 Expenses (a) Cost of Materials Consumed 2,257.68 1,683.39 2,600.91 7,463.57 (b) Purchase of Stock in trade 10.98 268.40 268.40 (c) Changes in Inventories of Finished goods and (209.51) (72.50) 53.71 264.32 Work-in-Progress (d) Direct Manufacturing Expenses - Power, Fuel 3,098.25 2,867.35 2,888.03 11,075.33 & Others (Refer note 5) (e) Employee Benefits Expense 625.42 581.65 600.11 2,446.56 (f) Finance Cost 226.05 208.41 156.40 754.01 (g) Depreciation and Amortisation Expense 676.45 700.06 538.23 2,442.46 (h) Other Expenses 667.86 807.07 1,272.80 3,897.22 Total Expenses 7,353.18 7,043.83 8,110.19 28,611.87 3 Profit before Tax (1-2) 130.24 229.81 753.57 1,07218 4 Tax Expense - Current tax 29.98 35.62 131.23 193.06 - Deferred tax (Refer note 4) (382.66) 38.42 82.94 128.53 Total Tax Expense (352.68) 74.04 214.17 321.59 5 Net Profit/ (Loss) after Tax (3-4) 482.92 155.77 539.40 750.59 6 Other Comprehensive Income (a) Items that will not be reclassified to the Statement of Profit and Loss - Remeasurement of net defined benefit liability 21.55 42.64 14.52 86.21 - Fair value gain on investments in equity instruments designated as at [Showing first 8,000 characters — download PDF for full document]